EyePoint Pharmaceuticals Vs. Celestica Industry Stock Comparison

Sell

15

EYPT
EyePoint Pharmaceuticals

Last Price:

$4.99

Seasonality Move:

11.72%

Buy

52

CLS
Celestica

Last Price:

$69.12

Seasonality Move:

9.9%

Sell

15

EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

The current EyePoint Pharmaceuticals [EYPT] share price is $4.98. The Score for EYPT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
EYPT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

52

Celestica (CLS) is a Buy

Is Celestica a Buy, Sell or Hold?

The current Celestica [CLS] share price is $69.19. The Score for CLS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
CLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

The EyePoint Pharmaceuticals share price today is $4.98

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

CLS Stock Price Chart

What is Celestica's stock price today?

The Celestica share price today is $69.19

The current trend is moderately bullish and CLS is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.39	Sell
Relative Strength Index (14 RSI):	31.64	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.62 - 6.88)	Sell
Bollinger Bands (100):	(6.15 - 8.99)	Sell

CLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	20.94	Buy
Relative Strength Index (14 RSI):	31.37	Sell
Chaikin Money Flow:	-6876679	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(81.03 - 97.89)	Sell
Bollinger Bands (100):	(82.61 - 115.11)	Sell

EYPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.61	Sell
20-day SMA:	6.24	Sell
50-day SMA:	6.6	Sell
200-day SMA:	8.35	Sell
8-day EMA:	5.52	Sell
20-day EMA:	5.97	Sell
50-day EMA:	6.57	Sell
200-day EMA:	8.85	Sell

CLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	82.69	Sell
20-day SMA:	87.38	Sell
50-day SMA:	105.52	Sell
200-day SMA:	76.67	Sell
8-day EMA:	75.5	Sell
20-day EMA:	56.08	Buy
50-day EMA:	30.47	Buy
200-day EMA:	9	Buy

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Celestica Earnings Growth & CLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.10 per share, an increase this year of $0.96 per share, and an increase next year of $1.06 per share.

EyePoint Pharmaceuticals Technical Analysis

	Mar 21	Mar 24	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3
	Mar								Apr
	21	24	25	26	27	28	31	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Celestica Technical Analysis

	Mar 21	Mar 24	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3
	Mar								Apr
	21	24	25	26	27	28	31	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):